Skip to main content
. 2020 Jul 19;25(10):e1457–e1463. doi: 10.1634/theoncologist.2020-0610
Title 4‐month disease control rate
Number of Patients Screened 28
Number of Patients Enrolled 26
Number of Patients Evaluable for Toxicity 25
Number of Patients Evaluated for Efficacy 25
Evaluation Method RECIST 1.1
Response Assessment OTHER n = 8 (32%)